First reported 27 Mar 2017•Latest report 11 Aug 2025
Definition
What this concern includes
Includes failures in regulatory, supplier or pharmacy controls specifically intended to verify customer authorisation or entitlement before medicinal products are supplied, or to enforce compliance with those supply requirements, including online-prescription guidance and wholesale medicinal-product transactions.
Not included
Excludes age and identity verification before online access to restricted medicines where authorisation or entitlement to supply medicinal products is not the concern.
Excludes medication quantity, prescribing, dispensing, administration or clinical-treatment failures that do not concern whether the customer is authorised or entitled to receive or supply medicinal products.
Excludes generic regulatory, guidance or sanctioning deficiencies not specifically tied to controls on medicinal-product supply to unauthorised customers.
Reports
2
Distinct published reports
Individual concerns
2
A report can raise multiple concerns
Date range
2017–2025
First to latest report issue date
Stated actions
9
Described in published responses
Reports over time
Reports over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Adams Pharmacy1
Booker Group Limited1
Brooker Group Limited1
Private limited company1
Type not available1
Concerns and responses across reports
Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.
Surrey
Concerns raised1
Failure to check customers’ authorisation or entitlement before supplying medicinal products
Responses linked to these concerns
Each statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.9
Action
Operate a medicine-specific customer qualification process requiring documentary verification, category checks, management sign-off and recorded entitlement before permitting purchases.
Stated by Booker Group LimitedStated completedThe respondent said that this action was complete when they made their response on 31 October 2025.
Action
Block medicinal-product purchases at the till for non-qualified customers without allowing staff to override the block.
Stated by Booker Group LimitedStated completedThe respondent said that this action was complete when they made their response on 31 October 2025.
Action
Require customers entering the restricted medicines area to sign a declaration confirming their registration to purchase medicines.
Stated by Booker Group LimitedStatus unclearThe respondent did not make the status of this action clear when they made their response on 31 October 2025.
Action
Update and distribute the Branch Manual with medicine-control procedures, including the requirement for relevant colleagues to confirm they understand and will follow them.
Stated by Booker Group LimitedStated completedThe respondent said that this action was complete when they made their response on 31 October 2025.
Action
Recheck customers’ entitlement to purchase medicines every two years, covering historical accounts and new registrations from January 2026.
Stated by Booker Group LimitedStated plannedThe respondent said that this action was planned when they made their response on 31 October 2025.
Action
Provide annual online GDP training with a competency test and restrict medicine sales duties to colleagues achieving the required pass mark.
Stated by Booker Group LimitedStated completedThe respondent said that this action was complete when they made their response on 31 October 2025.
Action
Operate branch medicine audits by Responsible Persons, documenting deviations through corrective and preventive action plans.
Stated by Booker Group LimitedStated completedThe respondent said that this action was complete when they made their response on 31 October 2025.
Action
Conduct periodic senior-management and Responsible Person reviews of Quality Management System objectives, corrective actions and process improvements.
Stated by Booker Group LimitedStated completedThe respondent said that this action was complete when they made their response on 31 October 2025.
Action
Control access to medicinal products through locked storage, staff accompaniment and prominent notices restricting bulk sales to appropriately qualified trade customers.
Stated by Booker Group LimitedStated completedThe respondent said that this action was complete when they made their response on 31 October 2025.
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.1
Position
Existing QMS changes, including tighter qualification and a till block, are considered sufficient; no further action is required.
Stated by Booker Group LimitedExisting arrangements considered sufficientThe respondent said that existing arrangements were sufficient, so no further action was needed.
Manchester South
Concerns raised1
Failure to control and document consent for interchangeable collection of prescriptions
Responses linked to these concerns
Each statement is shown once, even when linked to more than one concern.
No linked response statements
No respondent-stated action or position is linked to these concerns in the published data.
Pin
Get email alerts
Request correction
Includes failures in regulatory, supplier or pharmacy controls specifically intended to verify customer authorisation or entitlement before medicinal products are supplied, or to enforce compliance with those supply requirements, including online-prescription guidance and wholesale medicinal-product transactions.
